PCV21, 20vPCV — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12-01 in 4mo
ESTIMATED |
READOUT
Study of the Safety and Immunogenicity of Catch-up Vaccination With a 21-valent
Phase 3 · Pneumococcal Infections |
SNY Sanofi | PCV21, 20vPCV |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|